Varanese Lauren, Xu Lily, Peters Christine E, Pintilie Grigore, Roberts David S, Raj Suyash, Liu Mengying, Ooi Yaw Shin, Diep Jonathan, Qiao Wenjie, Richards Christopher M, Callaway Jeremy, Bertozzi Carolyn R, Jabs Sabrina, de Vries Erik, van Kuppeveld Frank J M, Nagamine Claude M, Chiu Wah, Carette Jan E
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Bioengineering, Stanford University, Stanford, CA, USA.
Nature. 2025 Mar 25. doi: 10.1038/s41586-025-08908-0.
With the near eradication of poliovirus due to global vaccination campaigns, attention has shifted to other enteroviruses that can cause polio-like paralysis syndrome (now termed acute flaccid myelitis). In particular, enterovirus D68 (EV-D68) is believed to be the main driver of epidemic outbreaks of acute flaccid myelitis in recent years, yet not much is known about EV-D68 host interactions. EV-D68 is a respiratory virus but, in rare cases, can spread to the central nervous system to cause severe neuropathogenesis. Here we use genome-scale CRISPR screens to identify the poorly characterized multipass membrane transporter MFSD6 as a host entry factor for EV-D68. Knockout of MFSD6 expression abrogated EV-D68 infection in cell lines and primary cells corresponding to respiratory and neural cells. MFSD6 localized to the plasma membrane and was required for viral entry into host cells. MFSD6 bound directly to EV-D68 particles through its extracellular, third loop (L3). We determined the cryo-electron microscopy structure of EV-D68 in a complex with MFSD6 L3, revealing the interaction interface. A decoy receptor, engineered by fusing MFSD6 L3 to Fc, blocked EV-D68 infection of human primary lung epithelial cells and provided near-complete protection in a lethal mouse model of EV-D68 infection. Collectively, our results reveal MFSD6 as an entry receptor for EV-D68, and support the targeting of MFSD6 as a potential mechanism to combat infections by this emerging pathogen with pandemic potential.
由于全球疫苗接种运动,脊髓灰质炎病毒已接近根除,人们的注意力已转移到其他可导致脊髓灰质炎样麻痹综合征(现称为急性弛缓性脊髓炎)的肠道病毒。特别是,肠道病毒D68(EV-D68)被认为是近年来急性弛缓性脊髓炎流行爆发的主要驱动因素,但对EV-D68与宿主的相互作用了解甚少。EV-D68是一种呼吸道病毒,但在极少数情况下,可扩散至中枢神经系统,导致严重的神经病理发生。在此,我们利用全基因组CRISPR筛选,确定了特征不明的多次跨膜转运蛋白MFSD6是EV-D68的宿主进入因子。敲除MFSD6的表达可消除EV-D68在与呼吸道和神经细胞相对应的细胞系和原代细胞中的感染。MFSD6定位于质膜,是病毒进入宿主细胞所必需的。MFSD6通过其细胞外第三环(L3)直接与EV-D68颗粒结合。我们确定了与MFSD6 L3形成复合物的EV-D68的冷冻电子显微镜结构,揭示了相互作用界面。通过将MFSD6 L3与Fc融合构建的诱饵受体,可阻断EV-D68对人原代肺上皮细胞的感染,并在EV-D68感染的致死小鼠模型中提供近乎完全的保护。总体而言,我们的研究结果揭示了MFSD6是EV-D68的进入受体,并支持将MFSD6作为一种潜在机制进行靶向,以对抗这种具有大流行潜力的新兴病原体的感染。